Artificial breast implant provided on the surface threof with silicon open cell foam layer, and method for producing the same

Abstract

Disclosed are an artificial breast implant in which the surface thereof is formed or modified with a silicone open cell (open pore) foam layer, and a method for producing the same. More specifically, disclosed are an artificial breast implant that has a surface including an open cell foam layer made of silicone and thus minimizes side effects such as in vivo rejection, which may occur after implantation of the implant into the body, in particular, the occurrence of capsular contracture to achieve superior biocompatibility and safety, and a method for producing the same.

Description

REFERENCE TO RELATED APPLICATIONS[0001]This is a continuation of pending International Patent Application PCT / KR2010 / 001826 filed on Apr. 12, 2010, which designates the United States and claims priority of Korean Patent Application No. 10-2009-0112022 filed on Nov. 19, 2009, the entire contents of which are incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to an artificial breast implant, the surface of which is formed or modified with a silicone open cell (open pore) foam layer, and a method for producing the same. More specifically, the present invention relates to an artificial breast implant that has an open cell foam layer made of silicone on the surface thereof and thus minimizes side effects such as in vivo rejection, which may occur after insertion of the implant into the human body, in particular, the occurrence of capsular contracture to achieve superior biocompatibility and safety, and a method for producing the same.BACKGROUND OF ...

AI Technical Summary

Benefits of technology

[0028]The present invention has been made in view of the above problems of the related art, and it is one object of the present invention to provide an artificial breast implant that minimizes capsular contracture, which may occur after insertion of the implant into the human body, and thus achieves superior biocompatibility and safety.

[0029]It is another object of the present invention to provide an artificial breast implant that minimizes occurrence of capsular contracture and exhibits superior durability.

[0031]According to the present invention, the artificial breast implant includes a silicone open cell foam layer on the surface thereof, thus minimizing a side effect such as capsular contracture, which may occur after insertion of the implant into the human body. In addition, the artificial breast implant includes a silicone foam layer with a uniform thickness present on the silicone shell, thus preventing occurrence of stress concentration, and exhibiting superior durability, as compared to conventional textured surface silicone artificial breast implants.

Problems solved by technology

Although the saline filled artificial breast prosthesis ensures safety of a user even if the filling material leaks into the human body after rupture of the shell as a result of using sterile saline as the filling material, and is easy to change the volume of a breast by adjusting the injection amount of saline, the saline filled artificial breast prosthesis is significantly deteriorated to the touch after surgery as compared to other artificial breast prostheses and the shell thereof has inferior durability.

However, in the case of the hydro-gel filled artificial breast prosthesis, safety with respect to long term use has not been established, volume change depending on the lapse of time and occurrence of wrinkles may increase after the artificial breast prosthesis is inserted into the human body, and feeling is unnatural as compared to a silicone gel filled artificial breast prosthesis.

At present, the above described hydro-gel filled artificial breast prostheses are not distributed on the market on the basis of the year 2000 due to problems in relation to the proof of safety.

This prosthesis has caused gel bleed and capsular contracture, but a rupture speed thereof was relatively low due to the use of the thick shell.

First, in the case of rupture, an event in which Dow Corning sold the prosthesis was bankrupted due to rupture of a great amount of the second generation silicone gel filled artificial breast prosthesis using a thin shell is well-known.

Second, capsular contracture is a natural biological rejection reaction in which collagen films are firmly accumulated around a prosthesis, after insertion of the implant into the human body, which is observed in all patients that undergo artificial breast prosthesis surgery, but there is a difference in severity of capsular contracture therebetween.

Of these, artificial breast implants in which urethane foams developed by methods described in U.S. Pat. No. 3,366,975 and U.S. Pat. No. 3,683,424 formed on the surfaces thereof are known to exhibit the greatest effects on reduction of capsular contracture, but such a method and product are not used at present due to the problem associated with safety of urethane in the body.

Of these methods, except the method of forming a urethane foam on the surface of an artificial breast, other methods simply make the surface of the artificial breast rough and have lower efficacy in terms of reduction of capsular contracture as compared to urethane foam artificial breasts.

The reason for this is that except the method of forming a urethane foam on the surface of the artificial breast, other methods are low in uniform deposition and hardening prevention of collagen films on the surface of implants, as compared to urethane implants, since a textured surface form, more specifically, textured mono-layer, not a foam layer, is formed on the surface of the artificial breast.

As described above, the development and progress in terms of safety of silicone artificial breast implants have focused on decrease in rupture and capsular contracture, but methods developed to date are not complete in technical regards, and in particular, have a high capsular contracture onset as a side effect, thus entailing considerably frequent removal and re-operation of the implants.

Images